Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
The American Journal of Psychiatry
|
March 7, 2001
Pramipexole augmentation in panic with agoraphobia
D Marazziti, S Presta, C Pfanner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
Comorbidity in obsessive-compulsive disorder: focus on depression
A Milanfranchi, D Marazziti, C Pfanner, et al.
International Clinical Psychopharmacology
|
September 19, 2000
Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study
C Pfanner, D Marazziti, L Dell'Osso, et al.
Neuropsychobiology
|
April 5, 2001
No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients
D Marazziti, L Conti, C Pfanner, et al.
International Clinical Psychopharmacology
|
July 19, 2001
Citalopram in refractory obsessive-compulsive disorder: an open study
D Marazziti, L Dell'Osso, A Gemignani, et al.
Neuropsychobiology
|
January 1, 1996
Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients
D Marazziti, A Rossi, A Gemignani, et al.
Biological Psychiatry
|
September 24, 1999
Immunological alterations in adult obsessive-compulsive disorder
D Marazziti, S Presta, C Pfanner, et al.
Pharmacopsychiatry
|
January 27, 1998
Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine
D Marazziti, C Pfanner, L Palego, et al.
Journal of Affective Disorders
|
December 5, 1997
The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder
G Perugi, H S Akiskal, C Pfanner, et al.
Psychiatry Research
|
March 9, 2000
Platelet [3H]paroxetine binding in patients with OCD-related disorders
D Marazziti, L Dell'Osso, S Presta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
The American Journal of Psychiatry
|
March 7, 2001
Pramipexole augmentation in panic with agoraphobia
D Marazziti, S Presta, C Pfanner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
Comorbidity in obsessive-compulsive disorder: focus on depression
A Milanfranchi, D Marazziti, C Pfanner, et al.
International Clinical Psychopharmacology
|
September 19, 2000
Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study
C Pfanner, D Marazziti, L Dell'Osso, et al.
Neuropsychobiology
|
April 5, 2001
No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients
D Marazziti, L Conti, C Pfanner, et al.
International Clinical Psychopharmacology
|
July 19, 2001
Citalopram in refractory obsessive-compulsive disorder: an open study
D Marazziti, L Dell'Osso, A Gemignani, et al.
Neuropsychobiology
|
January 1, 1996
Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients
D Marazziti, A Rossi, A Gemignani, et al.
Biological Psychiatry
|
September 24, 1999
Immunological alterations in adult obsessive-compulsive disorder
D Marazziti, S Presta, C Pfanner, et al.
Pharmacopsychiatry
|
January 27, 1998
Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine
D Marazziti, C Pfanner, L Palego, et al.
Journal of Affective Disorders
|
December 5, 1997
The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder
G Perugi, H S Akiskal, C Pfanner, et al.
Psychiatry Research
|
March 9, 2000
Platelet [3H]paroxetine binding in patients with OCD-related disorders
D Marazziti, L Dell'Osso, S Presta, et al.
Page
of 2